Come up with a name for your new list and we'll add to it:
RhinoCyte raised a round of funding on November 18, 2011. Investors include
Kentucky Seed Capital Fund.
RhinoCyte is a biotechnology company that has developed a method of isolating adult stem cells located in the olfactory regions of the mucosal lining of the human nasal passageway, which can be used i…